Mark J Alles

Mark J Alles has an estimated net worth of $28.5 Million. This is based on reported shares across multiple companies, which include Turning Point Therapeutics, Inc., BIOMARIN PHARMACEUTICAL INC, Syros Pharmaceuticals, Inc., and CELGENE CORP /DE/.

2015 was Mark J Alles's most active year for acquiring shares with 44 total transactions. Mark J Alles's most active month to acquire stocks was the month of January. 2015 was Mark J Alles's most active year for disposing of shares, totalling 42 transactions. Mark J Alles's most active month to dispose stocks was the month of January. 2013 saw Mark J Alles paying a total of $6,330,262.96 for 199,471 shares, this is the most they've acquired in one year. In 2013 Mark J Alles cashed out on 244,966 shares for a total of $16,397,873.10, their largest year based on trade value.